Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 6, 2012, Pages 969-979

  Ahearn, Thomas U ^a   Shaukat, Aasma ^c   Flanders, W Dana ^a,b   Seabrook, March E ^d   Bostick, Roberd M ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; BIOLOGICAL MARKER; CALCIFEDIOL; UVOMORULIN;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; COLORECTAL ADENOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTESTINE CRYPT; MALE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; VITAMIN BLOOD LEVEL;

24,25-DIHYDROXYVITAMIN D 3; ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; CADHERINS; CASE-CONTROL STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PILOT PROJECTS; RISK FACTORS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84862870790     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0126     Document Type: Article

References (38)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
2. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007.
3. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32. (Pubitemid 29272518)
4. Goss KH, Groden J. Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol 2000;18:1967-79. (Pubitemid 30261936)
5. Willert K, Jones KA. Wnt signaling: is the party in the nucleus? Genes Dev 2006;20:1394-404. (Pubitemid 43830647)
6. Iwamoto M, Ahnen DJ, Franklin WA, Maltzman TH. Expression of β-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis 2000;21:1935-40.
7. Day RM, Hao X, Ilyas M, Daszak P, Talbot IC, Forbes A. Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence. Virchows Archiv 1999;434:121-5. (Pubitemid 29184989)
8. Pap Z, Pavái Z,Dénes L, Kovalszky I, Jung J. An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1. Pathol Oncol Res 2009;15:579-87.
9. Daniel CR, Bostick RM, Flanders WD, Long Q, Fedirko V, Sidelnikov E, et al. TGF-α expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma. Cancer Epidemiol Biomark Prev 2009; 18:65-73.
10. Sidelnikov E, Bostick RM, FlandersWD, Long Q, Cohen VL, Dash C, et al. MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer. Cancer Epidemiol Biomark Prev 2009;18: 1599-609.
11. Sidelnikov E, Bostick RM, Flanders WD, Long Q, Seabrook ME. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms. Cancer Epidemiol Biomark Prev 2009;18:2965-73.
12. Pereira MA, FitzerGerald SJ, Gregg EW, Joswiak ML, Ryan WJ, Suminski RR, et al. A collection of Physical Activity Questionnaires for health-related research. Med Sci Sports Exerc 1997;29:S1-205.
13. Willett WC, Sampson L, Browne ML, Stampfer MJ, Rosner B, Hennekens CH, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988;127:188-99. (Pubitemid 18034380)
14. Willett WC,Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65. (Pubitemid 15010435)
15. O'Brien MJ, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, Diaz B, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990;98:371-9. (Pubitemid 20037919)
16. Fedirko V, Bostick RM, Flanders WD, Long Q, Shaukat A, Rutherford RE, et al. Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res 2009;2:213-23.
17. Bostick RM, Fosdick L, Lillemoe TJ, Overn P, Wood JR, Grambsch P, et al. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans. Cancer Epidemiol Biomark Prev 1997;6:931-42. (Pubitemid 27481642)
18. Saenger AK, Laha TJ, Bremner DE, Sadrzadeh SMH. Quantification of serum 25-hydroxyvitamin D2 and D3 using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of Vitamin D deficiency. Am J Clin Pathol 2006;125:914-20. (Pubitemid 43801542)
19. Long Q, Flanders WD, Fedirko V, Bostick RM. Robust statistical methods for analysis of biomarkers measured with batch/experiment- specific errors. Stat Med 2010;29:361-70.
20. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27. (Pubitemid 16095831)
21. Tsanou E, Peschos D, Batustatiu A, Charalabopoulos A, Charalabopoulos K. The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res 2008;28:3815-26.
22. Ahearn TU, McCullough ML, Flanders WD, Long Q, Sidelnikov E, Fedirko V, et al. A randomized clinical trial of the effects of supplemental calcium and vitamin D3 on markers of their metabolism in normal mucosa of colorectal adenoma patients. Cancer Res 2011;71:413-23.
23. Fedirko V, Bostick RM, Flanders WD, Long Q, Sidelnikov E, Shaukat A, et al. Effects of vitamin D and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial. Cancer Epidemiol Biomark Prev 2009;18:2933-41.
24. Fedirko V, Bostick RM, Long Q, Flanders WD, McCullough ML, Sidelnikov E, et al. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2010;19: 280-91.
25. Sidelnikov E, Bostick RM, Flanders WD, Long Q, Fedirko V, Shaukat A, et al. Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients. Cancer Epidemiol Biomarkers Prev 2010;19:1022-32.
26. Risio M, Coverlizza S, Ferrari A, Candelaresi GL, Rossini FP. Immunohistochemical study of epithelial cell proliferation in hyperplastic polyps, adenomas, and adenocarcinomas of the large bowel. Gastroenterology 1988;94:899-906.
27. Bostick RM, Fosdick L, Grandits GA, Lillemoe TJ, Wood JR, Grambsch P, et al. Colorectal epithelial cell proliferative kinetics and risk factors for colon cancer in sporadic adenoma patients. Cancer Epidemiol Biomark Prev 1997;6:1011-9. (Pubitemid 28007410)
28. Bostick RM, Fosdick L, Wood JR, Grambsch P, Grandits GA, Lillemoe TJ, et al. Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst 1995;87:1307-15.
29. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993;15:499-545. (Pubitemid 24072641)
30. Liu ES, Shin VY, Ye YN, Luo JC,WuWK,Cho CH. Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract. Eur J Pharmacol 2005;518:47-55. (Pubitemid 40968147)
31. Simanowski UA, Stickel F, Maier H, Gartner U, Seitz HK. Effect of alcohol on gastrointestinal cell regeneration as a possible mechanism in alcohol-associated carcinogenesis. Alcohol 1995;12:111-5.
32. Ruder EH, Thiébaut AC, Thompson FE, Potischman N, Subar AF, Park Y, et al. Adolescent and mid-life diet: risk of colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr 2011;94: 1607-19.
33. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 2005;97:179-94. (Pubitemid 41546228)
34. Fedirko V, Bostick RM, Goodman M, Flanders WD, Gross MD. Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol 2010; 172:489-500.
35. Liu Z, Choi S-W, Crott JW, Keyes MK, Jang H, Smith DE, et al. Mild depletion of dietary folate combined with other B vitamins alters multiple components of the Wnt pathway in mouse colon. J Nutr 2007;137:2701-8. (Pubitemid 350255301)
36. Liu Z, Ciappio ED, Crott JW, Brooks RS, Nesvet J, Smith DE, et al. Combined inadequacies of multiple B vitamins amplify colonic Wnt signaling and promote intestinal tumorigenesis in BAT-LacZxApc1638N mice. FASEB J 2011;25:3136-45.
37. Umar S, Morris AP, Kourouma F, Sellin JH. Dietary pectin and calcium inhibit colonic proliferation in vivo by differing mechanisms. Cell Prolif 2003;36:361-75. (Pubitemid 37500136)
38. Brenner BM, Russell N, Albrecht S, Davies RJ. The effect of dietary vitamin D3 on the intracellular calcium gradient in mammalian colonic crypts. Cancer Lett 1998;127:43-53. (Pubitemid 28230784)